|
|
Public Act 095-0239
|
| HB0457 Enrolled |
LRB095 04451 RLC 26428 b |
|
|
AN ACT concerning criminal law.
|
Be it enacted by the People of the State of Illinois,
|
represented in the General Assembly:
|
Section 5. The Illinois Controlled Substances Act is |
amended by changing Section 204 as follows:
|
(720 ILCS 570/204) (from Ch. 56 1/2, par. 1204)
|
Sec. 204. (a) The controlled substances listed in this |
Section are
included in Schedule I.
|
(b) Unless specifically excepted or unless listed in |
another
schedule, any of the following opiates, including their |
isomers,
esters, ethers, salts, and salts of isomers, esters, |
and ethers,
whenever the existence of such isomers, esters, |
ethers and salts is
possible within the specific chemical |
designation:
|
(1) Acetylmethadol;
|
(1.1) Acetyl-alpha-methylfentanyl
|
(N-[1-(1-methyl-2-phenethyl)-
|
4-piperidinyl]-N-phenylacetamide);
|
(2) Allylprodine;
|
(3) Alphacetylmethadol, except
|
levo-alphacetylmethadol (also known as levo-alpha-
|
acetylmethadol, levomethadyl acetate, or LAAM);
|
(4) Alphameprodine;
|
|
(5) Alphamethadol;
|
(6) Alpha-methylfentanyl
|
(N-(1-alpha-methyl-beta-phenyl) ethyl-4-piperidyl)
|
propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-
|
propanilido) piperidine;
|
(6.1) Alpha-methylthiofentanyl
|
(N-[1-methyl-2-(2-thienyl)ethyl-
|
4-piperidinyl]-N-phenylpropanamide);
|
(7) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP);
|
(7) 1-methyl-4-phenyl-4-proprionoxypiperidine (MPPP);
|
(7.1) PEPAP
|
(1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine);
|
(8) Benzethidine;
|
(9) Betacetylmethadol;
|
(9.1) Beta-hydroxyfentanyl
|
(N-[1-(2-hydroxy-2-phenethyl)-
|
4-piperidinyl]-N-phenylpropanamide);
|
(10) Betameprodine;
|
(11) Betamethadol;
|
(12) Betaprodine;
|
(13) Clonitazene;
|
(14) Dextromoramide;
|
(15) Diampromide;
|
(16) Diethylthiambutene;
|
(17) Difenoxin;
|
(18) Dimenoxadol;
|
|
(19) Dimepheptanol;
|
(20) Dimethylthiambutene;
|
(21) Dioxaphetylbutyrate;
|
(22) Dipipanone;
|
(23) Ethylmethylthiambutene;
|
(24) Etonitazene;
|
(25) Etoxeridine;
|
(26) Furethidine;
|
(27) Hydroxpethidine;
|
(28) Ketobemidone;
|
(29) Levomoramide;
|
(30) Levophenacylmorphan;
|
(31) 3-Methylfentanyl
|
(N-[3-methyl-1-(2-phenylethyl)-
|
4-piperidyl]-N-phenylpropanamide);
|
(31.1) 3-Methylthiofentanyl
|
(N-[(3-methyl-1-(2-thienyl)ethyl-
|
4-piperidinyl]-N-phenylpropanamide);
|
(32) Morpheridine;
|
(33) Noracymethadol;
|
(34) Norlevorphanol;
|
(35) Normethadone;
|
(36) Norpipanone;
|
(36.1) Para-fluorofentanyl
|
(N-(4-fluorophenyl)-N-[1-(2-phenethyl)-
|
4-piperidinyl]propanamide);
|
|
(37) Phenadoxone;
|
(38) Phenampromide;
|
(39) Phenomorphan;
|
(40) Phenoperidine;
|
(41) Piritramide;
|
(42) Proheptazine;
|
(43) Properidine;
|
(44) Propiram;
|
(45) Racemoramide;
|
(45.1) Thiofentanyl
|
(N-phenyl-N-[1-(2-thienyl)ethyl-
|
4-piperidinyl]-propanamide);
|
(46) Tilidine;
|
(47) Trimeperidine;
|
(48) Beta-hydroxy-3-methylfentanyl (other name:
|
N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-
|
N-phenylpropanamide).
|
(c) Unless specifically excepted or unless listed in |
another
schedule, any of the following opium derivatives, its |
salts, isomers
and salts of isomers, whenever the existence of |
such salts, isomers and
salts of isomers is possible within the |
specific chemical designation:
|
(1) Acetorphine;
|
(2) Acetyldihydrocodeine;
|
(3) Benzylmorphine;
|
(4) Codeine methylbromide;
|
|
(5) Codeine-N-Oxide;
|
(6) Cyprenorphine;
|
(7) Desomorphine;
|
(8) Diacetyldihydromorphine (Dihydroheroin);
|
(9) Dihydromorphine;
|
(10) Drotebanol;
|
(11) Etorphine (except hydrochloride salt);
|
(12) Heroin;
|
(13) Hydromorphinol;
|
(14) Methyldesorphine;
|
(15) Methyldihydromorphine;
|
(16) Morphine methylbromide;
|
(17) Morphine methylsulfonate;
|
(18) Morphine-N-Oxide;
|
(19) Myrophine;
|
(20) Nicocodeine;
|
(21) Nicomorphine;
|
(22) Normorphine;
|
(23) Pholcodine;
|
(24) Thebacon.
|
(d) Unless specifically excepted or unless listed in |
another
schedule, any material, compound, mixture, or |
preparation which contains
any quantity of the following |
hallucinogenic substances, or which
contains any of its salts, |
isomers and salts of isomers, whenever the
existence of such |
salts, isomers, and salts of isomers is possible
within the |
|
specific chemical designation (for the purposes of this
|
paragraph only, the term "isomer" includes the optical, |
position and
geometric isomers):
|
(1) 3,4-methylenedioxyamphetamine
|
(alpha-methyl,3,4-methylenedioxyphenethylamine,
|
methylenedioxyamphetamine, MDA);
|
(1.1) Alpha-ethyltryptamine
|
(some trade or other names: etryptamine;
|
MONASE; alpha-ethyl-1H-indole-3-ethanamine;
|
3-(2-aminobutyl)indole; a-ET; and AET);
|
(2) 3,4-methylenedioxymethamphetamine (MDMA);
|
(2.1) 3,4-methylenedioxy-N-ethylamphetamine
|
(also known as: N-ethyl-alpha-methyl-
|
3,4(methylenedioxy) Phenethylamine, N-ethyl MDA, MDE,
|
and MDEA);
|
(3) 3-methoxy-4,5-methylenedioxyamphetamine, (MMDA);
|
(4) 3,4,5-trimethoxyamphetamine (TMA);
|
(5) (Blank);
|
(6) Diethyltryptamine (DET);
|
(7) Dimethyltryptamine (DMT);
|
(8) 4-methyl-2,5-dimethoxyamphetamine (DOM, STP);
|
(9) Ibogaine (some trade and other names:
|
7-ethyl-6,6,beta,7,8,9,10,12,13-octahydro-2-methoxy-
|
6,9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b]
|
indole; Tabernanthe iboga);
|
(10) Lysergic acid diethylamide;
|
|
(10.5) Salvia divinorum (meaning all parts of the plant |
presently classified
botanically as Salvia divinorum, |
whether growing or not, the
seeds thereof, any extract from |
any part of that plant, and every compound,
manufacture, |
salts, isomers, and salts of
isomers whenever the existence |
of such salts, isomers, and salts of
isomers is possible |
within the specific chemical designation, derivative, |
mixture, or preparation of that plant, its
seeds or |
extracts);
|
(11) 3,4,5-trimethoxyphenethylamine (Mescaline);
|
(12) Peyote (meaning all parts of the plant presently |
classified
botanically as Lophophora williamsii
williemaii
|
Lemaire, whether growing or not, the
seeds thereof, any |
extract from any part of that plant, and every compound,
|
manufacture, salts, derivative, mixture, or preparation of |
that plant, its
seeds or extracts);
|
(13) N-ethyl-3-piperidyl benzilate (JB 318);
|
(14) N-methyl-3-piperidyl benzilate;
|
(14.1) N-hydroxy-3,4-methylenedioxyamphetamine
|
(also known as N-hydroxy-alpha-methyl-
|
3,4(methylenedioxy)phenethylamine and N-hydroxy MDA);
|
(15) Parahexyl; some trade or other names:
|
3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-
|
dibenzo (b,d) pyran; Synhexyl;
|
(16) Psilocybin;
|
(17) Psilocyn;
|
|
(18) Alpha-methyltryptamine (AMT);
|
(19) 2,5-dimethoxyamphetamine
|
(2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA);
|
(20) 4-bromo-2,5-dimethoxyamphetamine
|
(4-bromo-2,5-dimethoxy-alpha-methylphenethylamine;
|
4-bromo-2,5-DMA);
|
(20.1) 4-Bromo-2,5 dimethoxyphenethylamine.
|
Some trade or other names: 2-(4-bromo-
|
2,5-dimethoxyphenyl)-1-aminoethane;
|
alpha-desmethyl DOB, 2CB, Nexus;
|
(21) 4-methoxyamphetamine
|
(4-methoxy-alpha-methylphenethylamine;
|
paramethoxyamphetamine; PMA);
|
(22) (Blank);
|
(23) Ethylamine analog of phencyclidine.
|
Some trade or other names:
|
N-ethyl-1-phenylcyclohexylamine,
|
(1-phenylcyclohexyl) ethylamine,
|
N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE;
|
(24) Pyrrolidine analog of phencyclidine. Some trade |
or other names:
1-(1-phenylcyclohexyl) pyrrolidine, PCPy, |
PHP;
|
(25) 5-methoxy-3,4-methylenedioxy-amphetamine;
|
(26) 2,5-dimethoxy-4-ethylamphetamine
|
(another name: DOET);
|
(27) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine
|
|
(another name: TCPy);
|
(28) (Blank);
|
(29) Thiophene analog of phencyclidine (some trade
|
or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine;
|
2-thienyl analog of phencyclidine; TPCP; TCP);
|
(30) Bufotenine (some trade or other names:
|
3-(Beta-Dimethylaminoethyl)-5-hydroxyindole;
|
3-(2-dimethylaminoethyl)-5-indolol;
|
5-hydroxy-N,N-dimethyltryptamine;
|
N,N-dimethylserotonin; mappine).
|
(e) Unless specifically excepted or unless listed in |
another
schedule, any material, compound, mixture, or |
preparation which contains
any quantity of the following |
substances having a depressant effect on
the central nervous |
system, including its salts, isomers, and salts of
isomers |
whenever the existence of such salts, isomers, and salts of
|
isomers is possible within the specific chemical designation:
|
(1) mecloqualone;
|
(2) methaqualone; and
|
(3) gamma hydroxybutyric acid.
|
(f) Unless specifically excepted or unless listed in |
another schedule,
any material, compound, mixture, or |
preparation which contains any quantity
of the following |
substances having a stimulant effect on the central nervous
|
system, including its salts, isomers, and salts of isomers:
|
(1) Fenethylline;
|
|
(2) N-ethylamphetamine;
|
(3) Aminorex (some other names:
|
2-amino-5-phenyl-2-oxazoline; aminoxaphen;
|
4-5-dihydro-5-phenyl-2-oxazolamine) and its
|
salts, optical isomers, and salts of optical isomers;
|
(4) Methcathinone (some other names:
|
2-methylamino-1-phenylpropan-1-one;
|
Ephedrone; 2-(methylamino)-propiophenone;
|
alpha-(methylamino)propiophenone; N-methylcathinone;
|
methycathinone; Monomethylpropion; UR 1431) and its
|
salts, optical isomers, and salts of optical isomers;
|
(5) Cathinone (some trade or other names:
|
2-aminopropiophenone; alpha-aminopropiophenone;
|
2-amino-1-phenyl-propanone; norephedrone);
|
(6) N,N-dimethylamphetamine (also known as:
|
N,N-alpha-trimethyl-benzeneethanamine;
|
N,N-alpha-trimethylphenethylamine);
|
(7) (+ or -) cis-4-methylaminorex ((+ or -) cis-
|
4,5-dihydro-4-methyl-4-5-phenyl-2-oxazolamine).
|
(g) Temporary listing of substances subject to emergency |
scheduling.
Any material, compound, mixture, or preparation |
that contains any quantity
of the following substances:
|
(1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide
|
(benzylfentanyl), its optical isomers, isomers, salts,
|
and salts of isomers;
|
(2) N-[1(2-thienyl)
|